Loading clinical trials...
Loading clinical trials...
This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Edward R. Teitel, M.D.
NCT06535568 · Coronary Disease, Heart Diseases, and more
NCT07275541 · Platelet Aggregation, Kidney Transplant Rejection
NCT05967741 · Platelet Aggregation, Spontaneous, Vascular Thrombosis
NCT05702463 · Platelet Aggregation, Type 2 Diabetes, and more
NCT03462498 · Acute Coronary Syndrome, Acute Myocardial Infarction, and more
Aggredyne, Inc.
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions